Skip to main content
Mark Lewis, MD, Oncology, Sugar Land, TX, Intermountain Medical Center

MarkAndrewLewisMD

Oncology Sugar Land, TX

Assistant Professor, MD Anderson Cancer Center

Dr. Lewis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lewis' full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2012
  • Baylor Coll Med-Houston
    Baylor Coll Med-Houston2008 - 2009
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2006 - 2008
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 2005 - 2006
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2005
  • Rice University
    Rice UniversityBA, Biology & Ancient Mediterranean Civilizations, Summa Cum Laude, 1997 - 2001

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2016 - 2026
  • NV State Medical License
    NV State Medical License 2020 - 2025
  • ID State Medical License
    ID State Medical License 2018 - 2025
  • AZ State Medical License
    AZ State Medical License 2020 - 2025
  • CO State Medical License
    CO State Medical License 2020 - 2025
  • WY State Medical License
    WY State Medical License 2018 - 2024
  • MT State Medical License
    MT State Medical License 2020 - 2024
  • Join now to see all

Awards, Honors, & Recognition

  • Keynote addressee, The Methodist Hospital residency & fellowship commencement 2012
  • Edward C. Rosenow Outstanding Trainee Teaching Award 2011-2012, 2012
  • Dr. Tow Tan Humanism in Medicine award 2011-2012, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Treatment of Neuroendocrine Liver Metastases.  
    Lewis MA, Hobday TJ, International Journal of Hepatology. 2012: 973946
  • Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma.  
    Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA, Journal of Clinical Oncology
  • Treatment of Liver-Limited Disease from Colorectal Cancer.  
    Lewis MA, Hubbard J, Interventional Oncology
  • Join now to see all

Abstracts/Posters

  • Cutaneous Vasculitis Associated with All-Trans Retinoic Acid (ATRA) Therapy for Acute Promyelocytic Leukemia.
    Storan E, Lewis MA, Al-Kali A, European Academy of Dermatology and Venereology Annual Meeting
  • Post-recurrence survival in patients with previously resected esophageal adenocarcinoma (EAC).
    Lewis MA, Yoon HH, Shi Q, Diasio RB, Sinicrope FA, ASCO Annual Meeting. Abstract #95558
  • Preoperative Assessment of the MEN 1 Pancreas.
    Lewis M, Young WF, Thompson GB, World Journal of Surgery 35: 2011 (suppl 1; abstr 0895)
  • Join now to see all

Lectures

  • Talactoferrin as a novel therapeutic agent in metastatic renal cell carcinoma. 
    2007 Texas Society of Medical Oncology meeting, Houston, Texas
  • Oral talactoferrin (recombinant human lactoferrin) as a novel therapeutic agent in metastatic renal cell carcinoma. 
    2nd place in Clinical Research at 2008 Baylor College of Medicine Housestaff Research Symposium, TX

Press Mentions

  • Age 45 Is the New 50 for Colon Cancer Screening
    Age 45 Is the New 50 for Colon Cancer ScreeningSeptember 1st, 2021
  • Should There Be Universal Molecular Testing for All Patients with Gastrointestinal Cancer?
    Should There Be Universal Molecular Testing for All Patients with Gastrointestinal Cancer?July 23rd, 2021
  • Survey of Cancer Care Providers' Attitude Toward Care for Older Adults with Cancer During the COVID-19 Pandemic
    Survey of Cancer Care Providers' Attitude Toward Care for Older Adults with Cancer During the COVID-19 PandemicOctober 5th, 2020
  • Join now to see all

Hospital Affiliations